Home page > OLD Wealth and Equity | WTO Cancun Ministerial, September 2003

Access to Medicines

More about the ongoing talks at WTO to increase access to essential medicines, especially in developing countries.


Please find all related articles below.



[EU-US trade agreement] Briefing for EPHA members


EPHA is creating a briefing for its members to understand the potential impacts of the TTIP on public health. To add items to the briefing, please contact the EPHA Secretariat at leonardo@epha.org. The document is intended to raise awareness among EPHA members (plus their members) and EPHA partners. The Transatlantic Trade and Investment Partnership (TTIP) is a trade and investment agreement that is currently being negotiated between the European Union (EU) and the United States (US). (...)
18/02/2014

EPHA co-signs letter in support for a more coherent and rights-based policy approach towards migrant children and children’s rights


While the European Commission finalises its Communication on the future of Justice and Home Affairs policies, a number of migrants’ rights and children’s rights organisations, have written to the European Commission’s President Barroso to request a more coherent and rights-based policy approach towards migrant children. Specifically, the letter asks that future Home Affairs policy addresses existing shortcomings in meeting the EU’s legal obligations towards migrant (...)
18/02/2014

Motion for a European Parliament resolution on equal access to healthcare for children


At its latest plenary session in Strasbourg on 5 February 2014, the European Parliament voted for a motion for a resolution on equal access to healthcare for children. The motion was put forward by Sergio Paolo Francesco Silvestris MEP (EPP, Italy). Details of the motion for a resolution are given below: The European Parliament, – having regard to Rule 120 of its Rules of Procedure, A. whereas the right to health, meaning complete physical, mental and social wellbeing, has been (...)
10/02/2014

EPHA news feed on the prospective EU-US Trade Agreement (TTIP) & its potential impact on public health - Subscribe!!


This week EPHA launched a weekly news feed about the latest developments around the prospective Transatlantic Trade and Investment Partnership (TTIP) – a free trade agreement currently being negotiated between the EU and the US and the potential negative effect it may have on public health outcomes on both sides of the Atlantic. To learn more about this topic, you can read: [EU-US trade agreement] Would it benefit Europe’s public health? This digest will primarily focus on (...)
16/01/2014

[European Commission report] Personalised Medicine


The European Commission has recently published a Staff Working Document (SWD) exploring the potential of Personalised Medicine, reporting on recent developments in the EU legislation, as well as looking at the factors affecting the uptake of personalised medicine in healthcare systems. Personalised Medicine is now more close to be effective to patients, which means that treatments can be designed taking into account a specific patient group and hence able to tackle the problem with the (...)
18/11/2013

[Save the date] Dangerous side effects: The public health impact of investor-state dispute settlement


In the context of several ongoing and upcoming trade negotiating rounds with amongst others the United States, India and Thailand, civil society will debate with Members of Parliaments and experts the impacts of the agreements on public health. This follows the conclusion of the first ever EU-wide investment protection chapter, in the trade agreement with Canada WHEN: Tuesday 3 December 2013 (13:30-15:30) WHERE: Room ASP 3H1- European Parliament, Brussels Hosted by MEP Linda McAvan (...)
06/11/2013

[EU-US trade agreement] Would it benefit Europe’s public health?


In late October, EPHA attended a Transatlantic Consumer Dialogue’s (TACD) event intended to debate the prospective Transatlantic Trade and Investment Partnership (TTIP) between the EU and US and whether and how it is to benefit the consumers on both sides of the Atlantic. The event brought up a number of crucial considerations to be looked into what relate to public health issues. In a nutshell, this seminar stressed that the TTIP is mostly a drive towards de-regulation and a (...)
04/11/2013

[Joint Statement] Revisiting the Tallinn Charter: Health strengthening requires continuous investment in quality health services and health workforce


17 October 2013, Brussels - In the context of the World Health Organization’s (WHO) high-level meeting ‘Health systems for health and wealth in the context of Health 2020: Follow-up to the 2008 Tallinn Charter’ on 17-18 October 2013, EPHA has released a statement in collaboration with Medicus Mundi International and Health Workers 4all urging for continuous investment in quality health services and health workforce to achieve health strengthening. The original Tallinn (...)
17/10/2013

[WHO Regional Committee for Europe] Policy lessons and recommend ations from the evidence


At the 63rd session of the World Health Organization (WHO) regional committee for Europe in Çesme (Izmir, Turkey) on 16-19 September, generated ten policy lessons for health policy responses in times of global economic crisis. As Zsuzsanna Jakab, WHO’s Director for the Regional Office for Europe, explained, Ministers of Health have found out that providing effective social safety nets for people without work can largely mitigate the negative health effects of economic downturns. (...)
10/10/2013

Major Developments on Medicines for Children in the EU


On the 24th June 2013, the First European Commission Report on the Progress on Medicines for Children was released, after being prepared in consultation with the EMA and the Paediatric Committee. Since the enforcement of the Paediatric Regulation in 2007, there have been several developments in this area. Overall, the preliminary assessment introduced various improvements, like the following statement shows: “better and safer research, more medicines for children on the EU market and (...)
12/07/2013